Centene Corporation stock research
FY2024 Q3
Centene (CNC) Gross Margin — Quarter Ended Sep 30, 2024
Revenue rose while gross profit fell, leading to a lower gross margin. Cost of revenue was relatively stable sequentially but decreased from the prior year.
Gross margin takeaway
Quarter ended Sep 30, 2024 · FY2024 Q3
Revenue rose while gross profit fell, leading to a lower gross margin. Cost of revenue was relatively stable sequentially but decreased from the prior year.
- The decrease in gross profit was the strongest observable driver of the gross margin decline, as revenue continued to grow.
- Compared to the prior quarter, gross margin weakened; revenue was higher, but gross profit was lower. Year-over-year, gross margin also weakened, with revenue higher and gross profit lower.
Gross margin snapshot
The selected quarter's reported revenue, gross profit, direct costs, and margin comparisons.
Gross margin
10.9%
Gross profit
$4.0B
Revenue
$36.9B
Cost of revenue
$692.0M
Quarter-over-quarter change
-1.7 pts
Year-over-year change
-2.4 pts
Quarterly gross margin trend
A four-quarter view of the revenue and direct-cost bridge behind gross margin.
| Period | Revenue | Gross profit | Cost of revenue | Gross margin |
|---|---|---|---|---|
| Dec 31, 2023 | $35.3B | $3.7B | $961.0M | 10.6% |
| Mar 31, 2024 | $36.3B | $4.7B | $669.0M | 13.0% |
| Jun 30, 2024 | $36.0B | $4.5B | $680.0M | 12.6% |
| Sep 30, 2024 | $36.9B | $4.0B | $692.0M | 10.9% |
Quarterly comparisons
Compare the selected margin with the preceding quarter and the same fiscal quarter one year earlier.
Previous-quarter change
Jun 30, 2024
-1.7 pts
Year-over-year change
Sep 30, 2023
-2.4 pts
What the margin says
Filing-constrained interpretation of margin direction, comparisons, and what to monitor next.
The decrease in gross profit was the strongest observable driver of the gross margin decline, as revenue continued to grow.
Compared to the prior quarter, gross margin weakened; revenue was higher, but gross profit was lower. Year-over-year, gross margin also weakened, with revenue higher and gross profit lower.
Monitor the impact of the transition to a new third-party pharmacy benefit manager and risk adjustment payments on future margins, as noted in the liquidity discussion.